Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Regeneron Pharmaceuticals
(NQ:
REGN
)
781.49
-11.77 (-1.48%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 11, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
443,989
Open
800.00
Bid (Size)
780.00 (560)
Ask (Size)
784.25 (40)
Prev. Close
793.26
Today's Range
780.81 - 800.22
52wk Range
541.00 - 859.34
Shares Outstanding
91,779,465
Dividend Yield
0.48%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Regeneron Eyes 2026 Catalysts as EYLEA HD and DUPIXENT Drive Growth
↗
Today 3:02 EDT
Regeneron Pharmaceuticals (NASDAQ:REGN) executives outlined plans for continued growth across its commercial portfolio, upcoming regulatory milestones and pipeline programs during a Wells Fargo...
Via
MarketBeat
Topics
ETFs
REGN SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds Regeneron Investors of Securities Class Action Lawsuit Deadline on September 14, 2026
September 11, 2026
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
Performance
YTD
+0.7%
+0.7%
1 Month
-2.1%
-2.1%
3 Month
+27.7%
+27.7%
6 Month
+4.8%
+4.8%
1 Year
+37.5%
+37.5%
More News
Read More
MONDAY REGN INVESTOR DEADLINE: Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces
September 10, 2026
From
Robbins Geller Rudman & Dowd LLP
Via
Business Wire
Regeneron Pharmaceuticals (NASDAQ:REGN): A Credible Value Stock With a Meaningful Discount
↗
September 09, 2026
Via
Chartmill
REGENERNON PHARMACEUTICALS, INC. INVESTORS WITH LOSSES HAVE UNTIL SEPTEMBER 14, 2026 TO JOIN SECURITIES CLASS ACTION – Bernstein Liebhard LLP Announces Deadline
September 10, 2026
From
Bernstein Liebhard LLP
Via
GlobeNewswire
REGN Investors Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. Securities Fraud Lawsuit with SBS Law
September 10, 2026
From
Schall, Brown & Schwartz LLP
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Regeneron Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines – REGN
September 08, 2026
From
Pomerantz LLP
Via
GlobeNewswire
REGENERNON PHARMACEUTICALS, INC. (REGN) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Regeneron Pharmaceuticals, Inc. Investors of Upcoming Deadline
September 08, 2026
From
Bernstein Liebhard LLP
Via
GlobeNewswire
3 Reasons to Avoid REGN and 1 Stock to Buy Instead
September 08, 2026
Via
StockStory
Topics
Stocks
REGN Investors Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. Securities Fraud Lawsuit with SBS Law
September 07, 2026
From
Schall, Brown & Schwartz LLP
Via
GlobeNewswire
Vertex vs. Regeneron: Which Biotech Giant Is the Better Buy Right Now?
↗
September 04, 2026
Via
The Motley Fool
Topics
Intellectual Property
SEPTEMBER 14, 2026 REGN INVESTOR DEADLINE: Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces
September 04, 2026
From
Robbins Geller Rudman & Dowd LLP
Via
Business Wire
REGN Investors Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. Securities Fraud Lawsuit with SBS Law
September 03, 2026
From
Schall, Brown & Schwartz LLP
Via
GlobeNewswire
Here’s How Much You Would Have Made Owning Regeneron Pharmaceuticals Stock In The Last 15 Years
↗
September 02, 2026
Via
Benzinga
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Regeneron Pharmaceuticals, Inc. (REGN)
September 02, 2026
From
Bernstein Liebhard LLP
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Regeneron Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines – REGN
September 01, 2026
From
Pomerantz LLP
Via
GlobeNewswire
REGN Investors Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. Securities Fraud Lawsuit with SBS Law
August 31, 2026
From
Schall, Brown & Schwartz LLP
Via
GlobeNewswire
REGN Investors Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. Securities Fraud Lawsuit with SBS Law
August 27, 2026
From
Schall, Brown & Schwartz LLP
Via
GlobeNewswire
Robbins LLP Reminds REGN Stockholders of the Pending Lead Plaintiff Deadline in the Class Action Against Regeneron Pharmaceuticals, Inc.
August 26, 2026
Via
Newsfile
Topics
Earnings
Lawsuit
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Regeneron Pharmaceuticals, Inc. (REGN)
August 26, 2026
From
Bernstein Liebhard LLP
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Regeneron Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines – REGN
August 25, 2026
From
Pomerantz LLP
Via
GlobeNewswire
$100 Invested In Regeneron Pharmaceuticals 15 Years Ago Would Be Worth This Much Today
↗
August 24, 2026
Via
Benzinga
REGN Investors Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. Securities Fraud Lawsuit with SBS Law
August 24, 2026
From
Schall, Brown & Schwartz LLP
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Regeneron Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadlines – REGN
August 21, 2026
From
Pomerantz LLP
Via
GlobeNewswire
REGN Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Regeneron Pharmaceuticals Securities Lawsuit - Contact Levi & Korsinsky
August 20, 2026
From
Levi & Korsinsky, LLP
Via
Business Wire
Frequently Asked Questions
Is Regeneron Pharmaceuticals publicly traded?
Yes, Regeneron Pharmaceuticals is publicly traded.
What exchange does Regeneron Pharmaceuticals trade on?
Regeneron Pharmaceuticals trades on the Nasdaq Stock Market
What is the ticker symbol for Regeneron Pharmaceuticals?
The ticker symbol for Regeneron Pharmaceuticals is REGN on the Nasdaq Stock Market
What is the current price of Regeneron Pharmaceuticals?
The current price of Regeneron Pharmaceuticals is 781.49
When was Regeneron Pharmaceuticals last traded?
The last trade of Regeneron Pharmaceuticals was at 09/11/26 04:00 PM ET
What is the market capitalization of Regeneron Pharmaceuticals?
The market capitalization of Regeneron Pharmaceuticals is 71.72B
How many shares of Regeneron Pharmaceuticals are outstanding?
Regeneron Pharmaceuticals has 72B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.